Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL647262 | 0.78 | TSHR (0.31) | TSHRCYP2C19 | |
| SCHEMBL12133518 | 0.75 | TSHR (0.35) | TSHRCYP2C19 | |
| Hydrochloric Acid SCHEMBL1350431 | 0.75 | — | — | |
| SCHEMBL12133516 | 0.71 | — | — | |
| SCHEMBL8673856 | 0.68 | TSHR (0.44) | TSHRCYP2C19 | |
| SCHEMBL3431977 | 0.67 | — | — | |
| SCHEMBL1792526 | 0.67 | — | — | |
| SCHEMBL24760385 | 0.65 | — | — | |
| SCHEMBL28950862 | 0.65 | — | — | |
| SCHEMBL28540349 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025137256-A1 | POLYOXAZOLINE-CARBOHYDRATE-LIPID CONJUGATES | WU NIAN (US) | 2025-06-26 | — | — | WO | disclosed |
| EP-3313857-B1 | POLYMER-CYCLODEXTRIN-LIPID CONJUGATES | WU NIAN (US) | 2021-01-06 | — | — | EP | disclosed |
| US-10835608-B2 | Polymer-carbohydrate conjugates for drug delivery technology | LIPOSEUTICALS INC | 2020-11-17 | — | — | US | disclosed |
| EP-3077006-B1 | POLYMER-CARBOHYDRATE CONJUGATES FOR DRUG DELIVERY TECHNOLOGY | WU NIAN (US) | 2020-08-19 | — | — | EP | disclosed |
| US-10064954-B2 | Polymer-cyclodextrin-lipid conjugates | LIPOSEUTICALS INC | 2018-09-04 | — | — | US | disclosed |
| EP-3313857-A1 | POLYMER-CYCLODEXTRIN-LIPID CONJUGATES | Wu, Nian (US) | 2018-05-02 | — | — | EP | disclosed |
| WO-2016209732-A1 | POLYMER-CYCLODEXTRIN-LIPID CONJUGATES | WU NIAN (US) | 2016-12-29 | — | — | WO | disclosed |
| US-20160375150-A1 | POLYMER-CYCLODEXTRIN-LIPID CONJUGATES | LIPOSEUTICALS INC | 2016-12-29 | — | — | US | disclosed |
| EP-3077006-A1 | POLYMER-CARBOHYDRATE CONJUGATES FOR DRUG DELIVERY TECHNOLOGY | Wu, Nian (US) | 2016-10-12 | — | — | EP | disclosed |
| WO-2015085173-A1 | POLYMER-CARBOHYDRATE CONJUGATES FOR DRUG DELIVERY TECHNOLOGY | WU NIAN (US) | 2015-06-11 | — | — | WO | disclosed |
| US-20150157721-A1 | POLYMER-CARBOHYDRATE CONJUGATES FOR DRUG DELIVERY TECHNOLOGY | LIPOSEUTICALS INC | 2015-06-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10835608-B2 | Polymer-carbohydrate conjugates for drug delivery technology | LIPC, FABP4, CETP | TSHR 2812/4885CYP2C19 93/4885 |
| US-10064954-B2 | Polymer-cyclodextrin-lipid conjugates | CETP, FABP4, PLIN3 | TSHR 3583/4885CYP2C19 54/4885 |
| US-20150157721-A1 | POLYMER-CARBOHYDRATE CONJUGATES FOR DRUG DELIVERY TECHNOLOGY | LIPC, FABP4, CETP | TSHR 2812/4885CYP2C19 93/4885 |
| US-20160375150-A1 | POLYMER-CYCLODEXTRIN-LIPID CONJUGATES | CETP, FADS2, FABP4 | TSHR 3545/4885CYP2C19 59/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.